Ignite Creation Date:
2024-05-06 @ 4:09 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04892472
Status:
RECRUITING
Last Update Posted:
2023-10-06
First Post:
2021-05-13
Brief Title:
EF-36Keynote B36 A Pilot Randomized Open-label Study of Tumor Treating Fields TTFields 150 kHz Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer
Sponsor:
NovoCure GmbH
Organization:
NovoCure Ltd
Organization Data
Organization:
NovoCure Ltd
Class:
INDUSTRY
Study ID:
EF- 36
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NovoCure GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |